Leadership Overview
Themis Medicare has 4 executives leading key functions including financial oversight, information technology, corporate governance, and strategic operations.
Committed to advancing global health through pharmaceutical innovation, Themis Medicare delivers high-quality medicinal solutions for cardiology, pain management, and anti-infectives while maintaining a strong focus on patient-centric research and development.
Committed to advancing global health through pharmaceutical innovation, Themis Medicare delivers high-quality medicinal solutions for cardiology, pain management, and anti-infectives while maintaining a strong focus on patient-centric research and development.
Leadership Roles at Themis Medicare
Tushar Dalal - Chief Financial Officer
Tushar Dalal, the Chief Financial Officer at Themis Medicare, directs all fiscal planning and capital allocation strategies. Managing the financial health of the organization, the Chief Financial Officer oversees budgetary controls and investment analysis to support the manufacturing of cardiology and pain management pharmaceuticals. Tushar Dalal ensures rigorous compliance with regulatory standards while optimizing resource distribution across the Indian market. By monitoring cash flow and profitability metrics, the Chief Financial Officer provides the necessary data for long-term expansion into new therapeutic categories. This leadership role involves close collaboration with the board to maintain fiscal transparency and shareholder value. Through precise financial modeling, the Chief Financial Officer mitigates operational risks associated with medicinal chemical production. Ultimately, Dalal secures the economic stability required for the company to continue delivering essential health and nutrition products to diverse patient populations.
Prakash Naringrekar - Chief Financial Officer & Company Secretary
Prakash Naringrekar, the Chief Financial Officer & Company Secretary at Themis Medicare, manages corporate governance and legal compliance alongside financial reporting. Overseeing the administrative framework, the Chief Financial Officer & Company Secretary ensures that all board activities align with statutory requirements for pharmaceutical entities. Prakash Naringrekar directs the preparation of financial statements and regulatory filings, providing clarity on the company's market position in cardiology and pain management. By coordinating shareholder relations and internal audits, the Chief Financial Officer & Company Secretary maintains high standards of corporate integrity. This leadership role involves navigating complex legal landscapes to facilitate smooth operational expansion. Through meticulous documentation and oversight, Naringrekar supports the strategic goals of the organization. Ultimately, the Chief Financial Officer & Company Secretary provides the structural foundation necessary for the company to thrive while adhering to strict industry regulations and ethical business practices.
Muraridutt Sharma - President
Muraridutt Sharma, the President at Themis Medicare, drives the overarching strategic vision for the manufacturing of pharmaceuticals and medicinal chemicals. Overseeing the entire operational scope, the President coordinates cross-functional efforts in cardiology, pain management, and anti-infectives. Muraridutt Sharma leads the expansion of market reach, ensuring that health and nutrition products meet the needs of diverse patient demographics. By fostering innovation within the research and development departments, the President accelerates the delivery of new therapeutic solutions. This leadership role involves setting long-term objectives and aligning the company's resources with global market trends. Through consistent engagement with the executive team, Sharma ensures that all departments operate with maximum efficiency and focus. Ultimately, the President maintains the company's reputation for excellence in the pharmaceutical sector, guiding the organization toward sustained growth and improved patient outcomes across all regional operations.
Reena Patel - Chief Information Officer
Reena Patel, the Chief Information Officer at Themis Medicare, architects the digital infrastructure supporting pharmaceutical manufacturing and supply chain logistics. Overseeing the integration of advanced data systems, the Chief Information Officer drives technological efficiency across all production facilities. Reena Patel manages cybersecurity protocols to protect proprietary research in anti-infectives and haematinics. By implementing scalable software solutions, the Chief Information Officer enhances communication between research laboratories and regional distribution centers. This leadership role involves modernizing IT frameworks to support real-time inventory tracking and quality control processes. Through the deployment of sophisticated analytics, the Chief Information Officer enables data-driven decision-making for the entire executive team. Patel ensures that all digital assets align with the company's mission to provide high-quality medicinal chemicals. Ultimately, the Chief Information Officer maintains the technological edge necessary for sustained growth within the competitive pharmaceutical landscape.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership IC
HA
NM
BS
Bharat Serums And Vaccines Limited (BSV) is one of India's fastest-growing biopharmaceutical companies, dedicated to developing a wide range of biological, biotech, and pharmaceutical products for over 50 years. The company focuses on critical therapeutic areas such as women's health, critical care, and assisted reproductive technology, aiming to improve health and save lives through innovative treatments. BSV is committed to enhancing the quality of life for patients globally, with a strong emphasis on research and development, supported by a team of over 60 scientists. As a part of the Mankind Group, BSV strives to widen accessibility to its products and deliver positive health outcomes.
Company Leadership SP
RA
AD
Amgen Inc. (Nasdaq: AMGN) is a leading American multinational biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the biotech industry and remains at the forefront of scientific innovation.
Company Leadership LF
MC
Neuland is a leading Hyderabad based manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemistry related services. Our core competence lies in the application of strong process chemistry to manufacturing in regulatory environment. For 25 years, Neuland has been at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company's technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
Company Leadership HP
DP
AM